[1] SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
[2] UCHINO K, TATEISHI R, SHIINA S, et al. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors[J]. Cancer, 2011, 117(19):4475-4483.
[3] 朴美慈, 金仁顺. 肝细胞癌转移至下颌牙龈一例[J]. 中华肿瘤杂志,2020,42(12):1077-1078.
[4] 徐懿, 贺晓彤, 戴薇,等. 肝内胆管细胞癌牙龈转移1例及文献回顾[J]. 口腔颌面外科杂志,2020,30(4):260-263.
[5] CARPENTER K, DECATER T, IWANAGA J, et al. Revisiting the vertebral venous plexus-a comprehensive review of the literature[J]. World Neurosurg, 2021, 145:381-395.
[6] 孙向辉, 梁静, 王永兰,等. 肝硬化患者伴发慢性牙周炎的风险因素及营养状态分析[J]. 中华肝脏病杂志,2021,29(8):748-753.
[7] HOU Y, DENG W, DENG G, et al. Gingival metastasis from primary hepatocellular carcinoma: a case report and literature review of 30 cases[J]. BMC Cancer, 2019,19(1):925.
[8] KWON M J, RYU S H, JO S Y, et al. A case of hepatocellular carcinoma presenting as a gingival mass[J]. Korean J Gastroenterol, 2016, 68(6):321-325.
[9] GALLE PETER R, FINN RICHARD S, SHUKUI Q, et al. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial[J]. Lancet Oncology, 2021,22(7):991-1001.
[10] ANTONIA S J, VILLEGAS A, DANIEL D, et al. Durvalumab after chemoradiotherapy in stage Ⅲ non-small-cell lung cancer[J]. N Engl J Med, 2017, 377(20):1919-1929. |
